Prague Med. Rep. 2019, 120, 74-83
https://doi.org/10.14712/23362936.2019.12
The Role of Magnetic Resonance Spectroscopy Imaging Parameters to Predict Early Biochemical Recurrence after Radical Prostatectomy
References
1. 2000) Endorectal magnetic resonance imaging as a predictor of biochemical outcome after radical prostatectomy in men with clinically localized prostate cancer. J. Urol. 164(3), 759–763.
< , A. V., Whittington, R., Malkowicz, B., Schnall, M., Schultz, D., Cote, K., Tomaszewski, J. E., Wein, A. (https://doi.org/10.1016/S0022-5347(05)67297-7>
2. 2015) Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. Int. J. Cancer 136(5), E359–E386.
< , J., Soerjomataram, I., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., Parkin, D. M., Forman, D., Bray, F. (https://doi.org/10.1002/ijc.29210>
3. 2003) Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancer. J. Urol. 169(2), 517–523.
< , M., Partin, A. W., Zahurak, M., Piantadosi, S., Epstein, J. I., Walsh, P. C. (https://doi.org/10.1016/S0022-5347(05)63946-8>
4. 1998) A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer. J. Natl. Cancer Inst. 90(10), 766–771.
< , M. W., Eastham, J. A., Stapleton, A. M., Wheeler, T. M., Scardino, P. T. (https://doi.org/10.1093/jnci/90.10.766>
5. 2017) Prognostic factors for biochemical recurrence more than 10 years after radical prostatectomy. J. Urol. 197(1), 143–148.
< , L., Kron, M., Gschwend, J. E., Herkommer, K. (https://doi.org/10.1016/j.juro.2016.07.004>
6. 2011) Can we stop prostate specific antigen testing 10 years after radical prostatectomy? J. Urol. 186(2), 500–505.
< , S., Feng, Z., Ross, A., Trock, B. J., Humphreys, E. B., Walsh, P. C. (https://doi.org/10.1016/j.juro.2011.03.116>
<PubMed>
7. 2005) Global cancer statistics, 2002. CA Cancer J. Clin. 55(2), 74–108.
< , D. M., Bray, F., Ferlay, J., Pisani, P. (https://doi.org/10.3322/canjclin.55.2.74>
8. 1999) Natural history of progression after PSA elevation following radical prostatectomy. JAMA 281(17), 1591–1597.
< , C. R., Partin, A. W., Eisenberger, M. A., Chan, D. W., Pearson, J. D., Walsh, P. C. (https://doi.org/10.1001/jama.281.17.1591>
9. 2004) Preliminary assessment of magnetic resonance spectroscopic imaging in predicting treatment outcome in patients with prostate cancer at high risk for relapse. Clin. Prostate Cancer 3(3), 174–181.
< , D., Koutcher, J. A., Shah, A., Dyke, J. P., Schwartz, L., Thaler, H., Kurhanewicz, J., Scardino, P. T., Kelly, W. K., Hricak, H., Zakian, K. L. (https://doi.org/10.3816/CGC.2004.n.028>
10. 2007) The utility of magnetic resonance imaging and spectroscopy for predicting insignificant prostate cancer: an initial analysis. BJU Int. 99(4), 786–793.
< , A., Hricak, H., Kattan, M. W., Pucar, D., Kuroiwa, K., Chen, H. N., Spector, J., Koutcher, J. A., Zakian, K. L., Scardino, P. T. (https://doi.org/10.1111/j.1464-410X.2007.06689.x>
11. 2006) Preoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy. J. Natl. Cancer Inst. 98(10), 715–717.
< , A. J., Scardino, P. T., Eastham, J. A., Bianco, F. J. Jr., Dotan, Z. A., Fearn, P. A., Kattan, M. W. (https://doi.org/10.1093/jnci/djj190>
<PubMed>
12. 2016) PI-RADS Prostate Imaging – Reporting and Data System: 2015, Version 2. Eur. Urol. 69(1), 16–40.
< , J. C., Barentsz, J. O., Choyke, P. L., Cornud, F., Haider, M. A., Macura, K. J., Margolis, D., Schnall, M. D., Shtern, F., Tempany, C. M., Thoeny, H. C. (https://doi.org/10.1016/j.eururo.2015.08.052>
<PubMed>
13. 2010) An exploratory study of endorectal MRI and spectroscopy of the prostate as pre-operative predictive biomarkers of biochemical relapse after radical prostatectomy. J. Urol. 184(6), 2320.
< , K. L., Hricak, H., Ishill, N., Reuter, V. E., Eberhardt, S., Moskowitz, C. S., Shukla-Dave, A., Wang, L., Scardino, P. T., Eastham, J. A., Koutcher, J. A. (https://doi.org/10.1016/j.juro.2010.07.037>
<PubMed>
14. 2015) The histogram analysis of diffusion-weighted intravoxel incoherent motion (IVIM) imaging for differentiating the Gleason grade of prostate cancer. Eur. Radiol. 25(4), 994–1004.
< , Y. D., Wang, Q., Wu, C. J., Wang, X. N., Zhang, J., Liu, H., Liu, X. S., Shi, H. B. (https://doi.org/10.1007/s00330-014-3511-4>
15. 2017) MR-based prognostic nomogram for prostate cancer after radical prostatectomy. J. Magn. Reson. Imaging 45(2), 586–596.
< , Y. D., Wu, C. J., Bao, M. L., Li, H., Wang, X. N., Liu, X. S., Shi, H. B. (https://doi.org/10.1002/jmri.25441>